Search

Design Therapeutics Inc

Fechado

11.1 5.11

Visão Geral

Variação de preço das ações

24h

Atual

Mín

10.19

Máximo

10.92

Indicadores-chave

By Trading Economics

Rendimento

-2.5M

-20M

EPS

-0.32

Funcionários

55

EBITDA

-4.5M

-22M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+153.23% upside

Dividendos

By Acuity

Próximos Ganhos

3 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-59M

683M

Abertura anterior

5.99

Fecho anterior

11.1

Design Therapeutics Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

19 de out. de 2026, 23:56 UTC

AxoGen Inc is trading modestly lower in after-market hours, retracing from a brief rally that peaked above Monday's close.

19 de out. de 2026, 23:56 UTC

Sabre Corp shares advanced in after-market trading, recovering from earlier lows after a week-long decline, with a higher cumulative return.

19 de out. de 2026, 23:56 UTC

Royal Gold Inc is trading modestly higher in after-market hours, fluctuating around the middle of its one-month range without significant excursions.

19 de out. de 2026, 23:56 UTC

Axsome Therapeutics Inc shares are trading higher in after-market hours, having pulled back from an initial gain shortly after the market closed.

19 de out. de 2026, 23:56 UTC

CVR Energy Inc is trading higher in after-market hours, maintaining a steady position above its 20-day moving average since Monday's close.

19 de out. de 2026, 23:56 UTC

Jack Henry & Associates Inc is down in after-market trading, having pulled back from a session low earlier.

19 de out. de 2026, 23:56 UTC

Cognex Corp shares advanced modestly in after-market hours, recovering from a prior decline, but remain below their 20-day moving average.

19 de out. de 2026, 23:56 UTC

Hercules Capital Inc is trading lower in after-market hours, retreating to nearly the low end of its range since Monday's close.

19 de out. de 2026, 23:56 UTC

TE Connectivity PLC has advanced in after-market trading, reaching its highest point of the day after initially dipping following Monday's close.

19 de out. de 2026, 23:56 UTC

Cheesecake Factory Inc shares are trading modestly lower in after-market hours, retracing from an early high following a decline since Monday's close.

19 de out. de 2026, 23:56 UTC

Scholar Rock Holding Corp is trading higher in after-market hours, reaching a peak return shortly after the market reopened.

19 de out. de 2026, 23:56 UTC

Kroger Co shares are trading modestly higher in after-market hours, reaching their highest level since Monday's close and above the 20-day moving average.

19 de out. de 2026, 23:56 UTC

News

JP Morgan maintains Overweight rating on First Solar while lowering price target to $252, reflecting ongoing confidence in the company's future.

19 de out. de 2026, 23:56 UTC

Campbell's Co shares advanced modestly in after-market trading, maintaining stability and peaking before slightly retracing within the one-month trading range.

19 de out. de 2026, 23:53 UTC

PDD Holdings Inc. is advancing in after-market trading, reaching its highest level since Monday's close and remaining above its 20-day moving average.

19 de out. de 2026, 23:52 UTC

DraftKings Inc shares are trading modestly lower in after-market hours, remaining below Monday's close and near the lowest point of the day.

19 de out. de 2026, 23:51 UTC

Tootsie Roll Industries Inc shares advanced in after-market trading on Monday, recovering from earlier lows to a higher return by the latest observation.

19 de out. de 2026, 23:51 UTC

HealthStream Inc. is trading modestly lower in after-market hours, having retraced from a brief peak earlier in the session.

19 de out. de 2026, 23:51 UTC

Macy's Inc shares are trading modestly higher in after-market hours, recovering from earlier lows and positioned above its 20-day moving average.

19 de out. de 2026, 23:51 UTC

Tyson Foods Inc shares advanced modestly in after-market trading, remaining strong above the 20-day moving average and near the upper end of its one-month range.

19 de out. de 2026, 23:51 UTC

AMETEK Inc's shares advanced modestly in after-market trading, recovering from an initial dip and positioning around the middle of its one-month trading range.

19 de out. de 2026, 23:51 UTC

Social Media

Netflix Inc shares traded modestly lower during after-market hours on Monday, following the recent firing of its Chief Content Officer and film chief.

19 de out. de 2026, 23:51 UTC

Community Financial System Inc shares declined during after-market hours on Monday, reversing a trend of higher daily closes observed since last week.

19 de out. de 2026, 23:51 UTC

SentinelOne Inc shares advanced modestly in after-market hours, reaching a peak cumulative return since Monday's close, though still below its 20-day moving average.

19 de out. de 2026, 23:51 UTC

Event
News

Bristol-Myers Squibb announces BioNTech SE will present new clinical data at the ESMO 2026 Congress, featuring 16 abstracts on various tumor types.

19 de out. de 2026, 23:51 UTC

Zoetis Inc shares traded modestly lower in after-market hours, following a notable decline that has continued since Monday's close.

19 de out. de 2026, 23:51 UTC

U.S. Initial Jobless Claims Expected at 200K Amid Resilient Labor Market and Cautious Optimism in Financial Markets

19 de out. de 2026, 23:51 UTC

Pending Home Sales Expected to Decline 0.5% Amid Rising Mortgage Rates and Decreased Buyer Demand, Signaling Ongoing Challenges in Housing Market

19 de out. de 2026, 23:51 UTC

Pending Home Sales Data Release Expected to Reflect Decline Amid Rising Mortgage Rates and Affordability Concerns

19 de out. de 2026, 23:51 UTC

News

ServisFirst Bancshares reports Q3 earnings of $0.80 per share and revenue of $172.9 million, both below analyst expectations, contributing to a decline in after-market trading.

Comparação entre Pares

Variação de preço

Design Therapeutics Inc Previsão

Preço-alvo

By TipRanks

153.23% parte superior

Previsão para 12 meses

Média 26.108 USD  153.23%

Máximo 40.54 USD

Mínimo 20 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Design Therapeutics Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

5 ratings

5

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
help-icon Live chat